Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Informed consent and tardive dyskinesia.

R M Wettstein1

  • 1Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, Pennsylvania 15213.

Journal of Clinical Psychopharmacology
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authorship is broken.

The journal of the American Academy of Psychiatry and the Law·2001
Same author

Psychotherapists' duties to third parties revisited. Doe v. McKay.

Hospital law newsletter·2000
Same author

Emerich v. Philadelphia Center for Human Development: The new duty to warn in Pennsylvania.

The journal of the American Academy of Psychiatry and the Law·1999
Same author

The right to refuse psychiatric treatment.

The Psychiatric clinics of North America·1999
Same author

Toward the development of guidelines for the conduct of forensic psychiatric examinations.

The journal of the American Academy of Psychiatry and the Law·1997
Same author

Homicidal behavior and sleep apnea: a case report and medicolegal discussion.

Sleep·1995
Same journal

Are the 8 Finnish Deaths Explained by Agranulocytosis More Important than the Thousands of Suicide Deaths Associated with the Lack of Use of Clozapine? Reflections on Clozaphobia.

Journal of clinical psychopharmacology·2026
Same journal

Aripiprazole Withdrawal-Associated Restless Legs Syndrome During Clozapine Treatment in an Adolescent With Schizoaffective Disorder: A Case Report.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
Same journal

Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.

Journal of clinical psychopharmacology·2026
Same journal

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026
Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026
See all related articles

Tardive dyskinesia is common in chronically mentally ill patients requiring antipsychotic medication. Mental health professionals must navigate informed consent challenges to mitigate liability risks.

Area of Science:

  • Psychiatry
  • Neurology

Background:

  • Tardive dyskinesia (TD) is a significant concern for patients with serious mental illness.
  • These patients often require long-term antipsychotic medication, increasing TD risk.
  • The capacity of seriously mentally ill individuals to provide informed consent for treatment is often questioned.

Purpose of the Study:

  • To explore the challenges mental health professionals face in obtaining informed consent for antipsychotic medication in patients with tardive dyskinesia.
  • To discuss strategies for enhancing patient understanding of medication risks.
  • To highlight the legal implications of inadequate informed consent.

Main Methods:

  • Review of clinical literature and legal precedents regarding informed consent in psychiatric practice.
Keywords:
Legal ApproachMental Health TherapiesProfessional Patient RelationshipTardive Dyskinesia

Related Experiment Videos

  • Analysis of the prevalence and impact of tardive dyskinesia in chronically mentally ill populations.
  • Discussion of ethical considerations in managing antipsychotic treatment and informed consent.

    • Main Results:

    • Tardive dyskinesia presents complex ethical and practical dilemmas for clinicians.
    • There is a recognized need for effective strategies to ensure informed consent despite patient cognitive challenges.
    • Failure to obtain informed consent can lead to legal liability for clinicians.

    Conclusions:

    • Mental health professionals must strive to engage patients in the informed consent process, adapting methods to individual capacities.
    • Implementing strategies to improve patient comprehension of antipsychotic risks is crucial.
    • Addressing informed consent is essential for ethical practice and avoiding legal repercussions in treating the seriously mentally ill.